Rafarma Pharmaceuticals is a drugmaker that develops and distributes a range of medicinal products across Russia, including generic antibiotics, cephalosporin-based treatments, oncology medications, and drugs for conditions such as wound care and eye inflammation. The company formulates these medications in multiple delivery formats including tablets, capsules, injections, and oral suspensions for pediatric use. Additionally, Rafarma collaborates with PlantEXT Ltd. on developing cannabis-based suppositories intended for inflammatory bowel disease treatment.

entry readiness 65 · MODERATE · exit proximity 35

Value area 0.02–0.05 · 39% of 64d volume overhead · moderate overhead